Skip to main content

IMAGEN MOLECULAR Y DE FENOTIPO DE LA PROGRESION TUMORAL CEREBRAL EN MODELOS MURINOS. EXTENSION TRANSLACIONAL A HUMANOS.

SAF2008-03323

•
Funding agency name Ministerio de Ciencia e Innovación
Funding agency acronym MICINN
Program Programa Nacional de Proyectos de Investigación Fundamental
Subprogram Subprograma de Proyectos de Investigación Fundamental no Orientada
Call Proyectos I+D
Call year 2008
State Plan 2008-2011 Plan Nacional de Investigación Científica, Desarrollo e Innovación Tecnológica
Management unit Subdirección General de Proyectos de Investigación
Beneficiary centre UNIVERSIDAD AUTONOMA DE BARCELONA

IMAGEN MOLECULAR Y DE FENOTIPO DE LA PROGRESION TUMORAL CEREBRAL EN MODELOS MURINOS. EXTENSION TRANSLACIONAL A HUMANOS.

SAF2008-03323

•
Funding agency name Ministerio de Ciencia e Innovación
Funding agency acronym MICINN
Program Programa Nacional de Proyectos de Investigación Fundamental
Subprogram Subprograma de Proyectos de Investigación Fundamental no Orientada
Call Proyectos I+D
Call year 2008
State Plan 2008-2011 Plan Nacional de Investigación Científica, Desarrollo e Innovación Tecnológica
Management unit Subdirección General de Proyectos de Investigación
Beneficiary centre UNIVERSIDAD AUTONOMA DE BARCELONA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Prospective diagnostic performance evaluation of single-voxel 1H MRS for typing and grading of brain tumours

  • Julià Sapé, Ma. Margarita|||0000-0002-3316-9027
  • Coronel Linárez, Indira Evelia
  • Majos, Carles|||0000-0003-0468-5150
  • Candiota Silveira, Ana Paula|||0000-0002-1523-6505
  • Serrallonga, Marta
  • Cos, Mònica|||0000-0003-0827-7170
  • Aguilera, Carles
  • Acebes Martín, Juan José
  • GRIFFITHS, JOHN R
  • Arús i Caraltó, Carles|||0000-0003-2510-2671
The purpose of this study was to evaluate whether single-voxel 1H MRS could add useful information to conventional MRI in the preoperative characterisation of the type and grade of brain tumours. MRI and MRS examinations from a prospective cohort of 40 consecutive patients were analysed double blind by radiologists and spectroscopists before the histological diagnosis was known. The spectroscopists had only the MR spectra, whereas the radiologists had both the MR images and basic clinical details (age, sex and presenting symptoms). Then, the radiologists and spectroscopists exchanged their predictions and re-evaluated their initial opinions, taking into account the new evidence. Spectroscopists used four different systems of analysis for 1H MRS data, and the efficacy of each of these methods was also evaluated. Information extracted from 1H MRS significantly improved the radiologists' MRI-based characterisation of grade IV tumours (glioblastomas, metastases, medulloblastomas and lymphomas) in the cohort [area under the curve (AUC) in the MRI re-evaluation 0.93 versus AUC in the MRI evaluation 0.85], and also of the less malignant glial tumours (AUC in the MRI re-evaluation 0.93 versus AUC in the MRI evaluation 0.81). One of the MRS analysis systems used, the INTERPRET (International Network for Pattern Recognition of Tumours Using Magnetic Resonance) decision support system, outperformed the others, as well as being better than the MRI evaluation for the characterisation of grade III astrocytomas. Thus, preoperative MRS data improve the radiologists' performance in diagnosing grade IV tumours and, for those of grade II-III, MRS data help them to recognise the glial lineage. Even in cases in which their diagnoses were not improved, the provision of MRS data to the radiologists had no negative influence on their predictions.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Strategies for annotation and curation of translational databases: the eTUMOUR project

  • Julià Sapé, Ma. Margarita|||0000-0002-3316-9027
  • Lurgi Rivera, Miguel|||0000-0001-9891-895X
  • Mier, Mariola
  • Estanyol, Francesc
  • Rafael, Xavier
  • Candiota Silveira, Ana Paula|||0000-0002-1523-6505
  • Barceló Vernet, Anna|||0000-0002-5359-1698
  • Torres Garcia, Alina
  • Martínez Bisbal, M. Carmen
  • Ferrer Luna, Rubén
  • Moreno Torres, Angel
  • Celda Muñoz, Bernardo
  • Arús i Caraltó, Carles|||0000-0003-2510-2671
The eTUMOUR (eT) multi-centre project gathered in vivo and ex vivo magnetic resonance (MR) data, as well as transcriptomic and clinical information from brain tumour patients, with the purpose of improving the diagnostic and prognostic evaluation of future patients. In order to carry this out, among other work, a database-the eTDB-was developed. In addition to complex permission rules and software and management quality control (QC), it was necessary to develop anonymization, processing and data visualization tools for the data uploaded. It was also necessary to develop sophisticated curation strategies that involved on one hand, dedicated fields for QC-generated meta-data and specialized quèries and global permissions for senior curators and on the other, to establish a set of metrics to quantify its contents. The indispensable dataset (ID), completeness and pairedness indices were set. The database contains 1317 cases created as a result of the eT project and 304 from a previous project, INTERPRET. The number of cases fulfilling the ID was 656. Completeness and pairedness were heterogeneous, depending on the data type involved.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Development of robust discriminant equations for assessing subtypes of glioblastoma biopsies

  • Castells Domingo, Xavier
  • Acebes Martín, Juan José
  • Majos, Carles|||0000-0003-0468-5150
  • Boluda, Susana
  • Julià Sapé, Ma. Margarita|||0000-0002-3316-9027
  • Candiota Silveira, Ana Paula|||0000-0002-1523-6505
  • Ariño Carmona, Joaquín|||0000-0002-6774-2987
  • Barceló, Antonia
  • Arús i Caraltó, Carles|||0000-0003-2510-2671
In the preceding decade, various studies on glioblastoma (Gb) demonstrated that signatures obtained from gene expression microarrays correlate better with survival than with histopathological classification. However, there is not a universal consensus formula to predict patient survival. We developed a gene signature using the expression profile of 47 Gbs through an unsupervised procedure and two groups were obtained. Subsequent to a training procedure through leave-one-out cross-validation, we fitted a discriminant (linear discriminant analysis (LDA)) equation using the four most discriminant probesets. This was repeated for two other published signatures and the performance of LDA equations was evaluated on an independent test set, which contained status of IDH1 mutation, EGFR amplification, MGMT methylation and gene VEGF expression, among other clinical and molecular information. The unsupervised local signature was composed of 69 probesets and clearly defined two Gb groups, which would agree with primary and secondary Gbs. This hypothesis was confirmed by predicting cases from the independent data set using the equations developed by us. The high survival group predicted by equations based on our local and one of the published signatures contained a significantly higher percentage of cases displaying IDH1 mutation and non-amplification of EGFR. In contrast, only the equation based on the published signature showed in the poor survival group a significant high percentage of cases displaying a hypothesised methylation of MGMT gene promoter and overexpression of gene VEGF. We have produced a robust equation to confidently discriminate Gb subtypes based in the normalised expression level of only four genes.